AAAAAA
Results:
1-16
|
Results: 16
Authors:
Nagano, N
Miyata, S
Obana, S
Ozai, M
Kobayashi, N
Fukushima, N
Burke, SK
Wada, M
Citation: N. Nagano et al., Sevelamer hydrochloride (Renagel (R)), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renalinsufficiency, NEPH DIAL T, 16(9), 2001, pp. 1870-1878
Authors:
Davidson, MH
Toth, P
Weiss, S
McKenney, J
Hunninghake, D
Isaacsohn, J
Donovan, JM
Burke, SK
Citation: Mh. Davidson et al., Low-dose combination therapy with colesevelam hydrochloride and lovastatineffectively decreases low-density lipoprotein cholesterol in patients withprimary hypercholesterolemia, CLIN CARD, 24(6), 2001, pp. 467-474
Authors:
Burke, SK
Amin, NS
Incerti, C
Plone, MA
Lee, JW
Citation: Sk. Burke et al., Sevelamer hydrochloride (Renagel (R)), a phosphate-binding polymer, does not alter the pharmacokinetics of two commonly used antihypertensives in healthy volunteers, J CLIN PHAR, 41(2), 2001, pp. 199-205
Authors:
Nagano, N
Miyata, S
Obana, S
Eto, N
Fukushima, N
Burke, SK
Wada, M
Citation: N. Nagano et al., Renal mineral handling in normal rats treated with sevelamer hydrochloride(Renagel((R))), a noncalcemic phosphate binder, NEPHRON, 89(3), 2001, pp. 321-328
Authors:
Hunninghake, D
Insull, W
Toth, P
Davidson, D
Donovan, JM
Burke, SK
Citation: D. Hunninghake et al., Coadministration of colesevelam hydrochloride with atorvastatin lowers LDLcholesterol additively, ATHEROSCLER, 158(2), 2001, pp. 407-416
Authors:
Knapp, HH
Schrott, H
Ma, P
Knopp, R
Chin, B
Gaziano, JM
Donovan, JM
Burke, SK
Davidson, MH
Citation: Hh. Knapp et al., Efficacy and safety of combination simvastatin and colesevelam in patientswith primary hypercholesterolemia, AM J MED, 110(5), 2001, pp. 352-360
Authors:
Burke, SK
Citation: Sk. Burke, Renagel (R): reducing serum phosphorus in haemodialysis patients, HOSP MED, 61(9), 2000, pp. 622-627
Authors:
Burke, SK
Citation: Sk. Burke, In search of lesbian community in an electronic world, CYBERPSYC B, 3(4), 2000, pp. 591-604
Authors:
Chertow, GM
Burke, SK
Dillon, MA
Slatopolsky, E
Citation: Gm. Chertow et al., Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients (vol 14, pg 2907, 1999), NEPH DIAL T, 15(4), 2000, pp. 559-559
Authors:
Donovan, JM
Stypinski, D
Stiles, MR
Olson, TA
Burke, SK
Citation: Jm. Donovan et al., Drug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agent, CARDIO DRUG, 14(6), 2000, pp. 681-690
Authors:
Chertow, GM
Plone, M
Dillon, MA
Burke, SK
Slatopolsky, E
Citation: Gm. Chertow et al., Hyperparathyroidism and dialysis vintage, CLIN NEPHR, 54(4), 2000, pp. 295-300
Authors:
Chertow, GM
Burke, SK
Dillon, MA
Slatopolsky, E
Citation: Gm. Chertow et al., Long-term effects of sevelamer hydrochloride on the calcium x phosphate product and lipid profile of haemodialysis patients, NEPH DIAL T, 14(12), 1999, pp. 2907-2914
Authors:
Chertow, GM
Dillon, M
Burke, SK
Steg, M
Bleyer, AJ
Garrett, BN
Domoto, DT
Wilkes, BM
Wombolt, DG
Slatopolsky, E
Citation: Gm. Chertow et al., A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients, CLIN NEPHR, 51(1), 1999, pp. 18-26
Authors:
Bleyer, AJ
Burke, SK
Dillon, M
Garrett, B
Kant, KS
Lynch, D
Rahman, SN
Schoenfeld, P
Teitelbaum, I
Zeig, S
Slatopolsky, E
Citation: Aj. Bleyer et al., A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients, AM J KIDNEY, 33(4), 1999, pp. 694-701
Authors:
Slatopolsky, EA
Burke, SK
Dillon, MA
Citation: Ea. Slatopolsky et al., RenaGel (R), a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone, KIDNEY INT, 55(1), 1999, pp. 299-307
Authors:
Davidson, MH
Dillon, MA
Gordon, B
Jones, P
Samuels, J
Weiss, S
Isaacsohn, J
Toth, P
Burke, SK
Citation: Mh. Davidson et al., Colesevelam hydrochloride (Cholestagel) - A new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects, ARCH IN MED, 159(16), 1999, pp. 1893-1900
Risultati:
1-16
|